Navigation Links
Mylan Reports a 23% Increase in Fourth Quarter 2012 Adjusted Diluted EPS to $0.65
Date:2/27/2013

rgins were 50% as compared to adjusted gross profit of $2.94 billion and adjusted gross margins of 48% in the comparable prior year period. The increase in adjusted gross margin was the result of new product introductions and favorable pricing and volume on the EPIPEN® Auto-Injector.

Earnings from operations were $1.11 billion for the year ended December 31, 2012, compared to $1.01 billion for the comparable prior year period.  Adjusted earnings from operations for the year ended December 31, 2012 were $1.69 billion as compared to adjusted earnings from operations of $1.48 billion in the comparable prior year period. This increase was driven by higher gross profit in the current year, as discussed above, partially offset by increases in R&D and SG&A. R&D increased due primarily to the expenses related to the development of the respiratory and biologics programs as well as the timing of internal and external product development projects. SG&A increased as a result of increased marketing and employee benefit costs, including increased costs for retirement and post-employment programs.

Interest expense for the year ended December 31, 2012, totaled $308.7 million, compared to $335.9 million for the comparable prior year period. Adjusted interest expense for the year ended December 31, 2012 was $242.4 million as compared to adjusted interest expense of $286.1 million in the comparable prior year period.

Other income (expense), net, for the year ended December 31, 2012 was income of $3.4 million compared to expense of $14.9 million in the comparable prior year period.

Net earnings attributable to Mylan Inc. increased $104.0 million, or 19.4%, to $640.9 million for the year ended December 31, 2012 as compared to $536.8 million for the comparable prior year period. Adjusted earnings increased $193.7 million, or 21.7%, to $1.09 billion for the year ended December 31, 2012 as compared to adjusted earnings of $893.0 milli
'/>"/>

SOURCE Mylan Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related medicine technology :

1. Mylan Launches Innovative Portfolio of Antiretroviral Products for Treatment of HIV/AIDS in South Africa
2. Mylan Enhances Partnership with Biocon through Strategic Collaboration for Insulin Products
3. Mylan Schedules Fourth Quarter and Year End 2012 Financial Results Conference Call and Live Webcast
4. Mylan Appoints Melina Higgins and Rajiv Malik to Board of Directors
5. Mylan Announces Pricing of Senior Notes
6. Moodys and Standard & Poors Upgrade Mylan to Investment Grade Credit Ratings
7. Mylan Reports a 51% Increase in Third Quarter 2012 Adjusted Diluted EPS to $0.83
8. Mylan Selected as a Leading ARV Supplier to Indias National AIDS Control Organization
9. Pfizer and Mylan Team Up to Establish Exclusive Long-Term Strategic Collaboration to Drive Sustained Growth of Generics Business in Japan
10. Mylan Launches Lithium Carbonate Extended-Release Tablets USP
11. Mylan Launches Commercial Operations in India, Starting with a Broad, Innovative Portfolio of ARV Products to Treat HIV/AIDS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... 2015  AVACEN, Inc. announced today the issue by the ... medical technology platform supporting its unique Dry Heat Therapy AVACEN ... Logo - http://photos.prnewswire.com/prnh/20150630/227364LOGO ... 9,066,781 - Methods And Apparatus For Therapeutic Application of Thermal ... methods of use, referred to by the company as the ...
(Date:7/1/2015)... 1, 2015 Radiant Insights announce ... Oxygen Concentrators Market Shares, Strategy, and Forecasts, Worldwide, ... continuing growth as the aging population worldwide needs homecare ... conditions where oxygen is able to improve the quality ... have become affordable and support a mobile lifestyle even ...
(Date:7/1/2015)... , July 1, 2015 ... is expected to reach USD 49,119.2 million by 2020, ... Inc. Monitoring services is expected to remain the dominant ... USD 1,227.5 million in 2012, and an estimated CAGR ... (Logo: http://photos.prnewswire.com/prnh/20150105/723757 ) , Browse full ...
Breaking Medicine Technology:AVACEN Medical Patent Issued 2Stationary Oxygen Concentrators Market to Reach $2 Billion by 2021: Radiant Insights, Inc. 2Stationary Oxygen Concentrators Market to Reach $2 Billion by 2021: Radiant Insights, Inc. 3Stationary Oxygen Concentrators Market to Reach $2 Billion by 2021: Radiant Insights, Inc. 4mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 2mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 3mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 4mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 5
... following statement,by Andrea Kavanagh, Director of the Pure Salmon ... publish a study tomorrow that,shows sea lice from open ... wild fish stocks., "This study confirms what we ... havoc on wild salmon populations. If outbreaks of these,parasites ...
... Results, SOUTH SAN FRANCICSO, Calif., Dec. 13 ... announced that its oral syk,kinase inhibitor, R788 (tamatinib ... Arthritis (RA) patients in a,recently completed Phase 2 ... 150mg po bid (orally, twice daily), showed higher ...
Cached Medicine Technology:Rigel's R788 Demonstrates Significant Improvement in Rheumatoid Arthritis in Phase 2 Clinical Study 2Rigel's R788 Demonstrates Significant Improvement in Rheumatoid Arthritis in Phase 2 Clinical Study 3Rigel's R788 Demonstrates Significant Improvement in Rheumatoid Arthritis in Phase 2 Clinical Study 4Rigel's R788 Demonstrates Significant Improvement in Rheumatoid Arthritis in Phase 2 Clinical Study 5Rigel's R788 Demonstrates Significant Improvement in Rheumatoid Arthritis in Phase 2 Clinical Study 6
(Date:7/1/2015)... ... July 01, 2015 , ... Bunion Bootie, ... Customers purchasing two or more Bunion Booties directly from their website, ... Bootie temporarily corrects misaligned toes and its ultra thin properties allow for protection ...
(Date:7/1/2015)... ... July 01, 2015 , ... B. E. Smith, the only full-service leadership ... chief nursing officer recruitment for Capital Health in Pennington, N.J. ... E. Smith has recently placed more than 1,000 healthcare executives into organizations. , ...
(Date:7/1/2015)... ... ... Who doesn’t want a life filled with thriving positivity and high-life satisfaction? ... and life, and positive friendships and relationships? , Dr. Marsha W. Snyder explains ... Doctors. , With a focus on solving the epidemic of ill-being in the medical ...
(Date:7/1/2015)... ... July 01, 2015 , ... METTLER TOLEDO is ... larger-than-average weighing pans, ML-T balances give operators the room they need to carry ... real estate makes ML-T balances a perfect choice for day-to-day weighing in nearly ...
(Date:7/1/2015)... ... ... The executive team from Nutritional Products International, a ... and beauty products, announced the company was successful in forging some important new ... in Tampa, Florida. This specific ECRM trade show gives companies in the nutritional, ...
Breaking Medicine News(10 mins):Health News:Bunion Bootie, the #1 Non-Surgical Treatment for Bunion Pain, Announces Their Big Summer Sale 2Health News:Capital Health Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Capital Health Retains B. E. Smith to Recruit New Chief Nursing Officer 3Health News:Medical Doctor Explains The Healthy Effects of a Positive Outlook in New Book 2Health News:METTLER TOLEDO Launches Compact ML-T Balances: Larger Pan Offers Greater Weighing Flexibility in Tight Spaces 2Health News:NPI Executives Report Great Success at ECRM Conference 2
... University of Alabama at Birmingham (UAB) have been selected ... project is a national consortium of cutting-edge hospitals and ... patients with a kind of malignant brain tumor called ... UAB will serve as the only research site in ...
... Colo., July 9 If your eye ... inside!, would you use it? Probably not. ... commonly-used chemicals Dimethicone,Glyceryl Sterate, DMDM Hydantoin and ... and skin irritating emulsifiers and,preservatives., Most ...
... GCI Health meets global needs for the increasingly complex healthcare ... ... 9 Cohn & Wolfe has announced the,formation of GCI Health, ... the healthcare industry. GCI Health, which,will be led by Jill Dosik ...
... vote soon on legislation that would cut $39 ... July 9 Seniors across,Mississippi are speaking out ... legislation being considered in the U.S. Senate. The,legislation ... Medicare Advantage,program in Mississippi alone and severely cut ...
... Governor Edward G.,Rendell today signed House Bill 1150 ... protections for children and young,adults with Autism Spectrum ... medically necessary treatments,for individuals with autism up to ... essential services and treatments by building a stronger ...
... MONICA, Calif., July 9 Cord Blood,America, ... cord blood stem,cell preservation company ( http://www.cordblood-america.com ... of stem cells to families nationwide and,internationally, ... interviewed,about the Company,s achievements and future strategies ...
Cached Medicine News:Health News:UAB joins elite brain cancer research group 2Health News:Clean, Chemical-Free Eye Cream Evening Primrose Oil: The Puffy-Eye Cure 2Health News:Cohn & Wolfe Launches GCI Health, One of the World's Largest Healthcare Public Relations Firms 2Health News:Mississippi Seniors Speak Out Against Medicare Advantage Cuts 2Health News:Pennsylvania Governor Rendell Signs Bill Ensuring Continuity of Care for Children, Young Adults with Autism 2Health News:Cord Blood America CEO Matthew Schissler Details Aggressive Expansion Strategies in U.S. and Europe 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: